Most pharmacies in America don’t offer a treatment for colic. There is a solution, even if parents don’t know about it. ECRM® can help bring Delictase® to stores, so millions of parents can cope with excessively crying children.
BOCA RATON, Fla. (PRWEB) December 19, 2017
Neosante Health Solutions will bring its top-selling Delictase® Oral Drops, a lactase enzyme supplement used to battle baby colic, to January’s ECRM® EPPS event in Washington, D.C.
The Vitamin, Weight Management and Sports Nutrition Efficient Program Planning Sessions (EPPS) is a trade show where nutrition companies like Neosante Health Solutions network with major retail buyers in private sessions to show off their products. EPPS has the potential to grow Delictase® Oral Drops and other Neosante products in the U.S. market, helping prevent excessive crying of babies due to common digestive issues, such as colic.
“ECRM® events let new and foreign brands get into the U.S. market,” Neosante CEO João Santos said. “Products like ours can really help out with child nutrition at the most important stage.
“Most pharmacies in America don’t offer a treatment for colic. There is a solution, even if parents don’t know about it. ECRM® can help bring Delictase® to stores, so millions of parents can cope with excessively crying children.”
EPPS is a branch of the Efficient Collaborative Retail Marketing (ECRM®) event series held Jan. 7-11 at the Hilton Washington in Washington, D.C. Brands are able to have direct discussions with retailers and other brands about business objectives like product launches, marketing campaigns and more. Some of the major retailers include Amazon.com, Costco, CVS, GNC, Harris Teeter, LuckyVitamin.com, Meijer, Sam’s Club, The Fresh Market, Vitamin Shoppe, Walgreens, Whole Foods and more.
Lactase is essential for complete digestion of lactose, found in breast milk and baby formula. Delictase® provides lactase to infants, who may have a lactase deficiency known as hypolactasia. Delictase® Oral Drops come in a 15 milliliter solution, prepackaged in a dropper. It is designed for infants to have with their breast milk or baby formula.
Neosante sold more than two million vials of Delictase® Oral Drops in 2017 alone, predominately to health-conscious parents coping with baby colic.